Table 1 Baseline clinical characteristics of patients during neonatal period (N = 72)
Features | Results |
|---|---|
Male/female, n/n (%/%) | 46/26 (63.9/36.1) |
Gestational age, n (%) | |
 24- < 28 weeks | 6 (8.3) |
 28- < 32 weeks | 17 (23.6) |
 32- < 36 weeks | 12 (16.7) |
 36–42 weeks | 37 (51.4) |
Birth weight, n (%) | |
 500–999 g | 9 (12.5) |
 1,000–1,499 g | 12 (16.7) |
 1,500–2,499 g | 15 (20.8) |
 2,500–3,999 g | 34 (47.2) |
 4,000–5,000 g | 2 (2.8) |
 Small for gestational age | 8 (11.1) |
 Large for gestational age | 9 (12.5) |
Systemic diseasesa, n (%) | |
 Sepsis | 30 (41.6) |
 Patent ductus arteriosus | 25 (34.7) |
 Respiratory distress syndrome | 20 (27.7) |
 Cardiac insufficiency | 16 (22.2) |
 Disseminated intravascular coagulopathy | 12 (16.7) |
 Necrotizing enterocolitis | 11 (15.2) |
Median age at AKI diagnosis (days) | 5 (IQR 6) |
 0–3 days, n (%) | 14 (19.4) |
 4–7 days, n (%) | 36 (50.0) |
 8–14 days, n (%) | 11 (15.3) |
 > 14 days, n (%) | 11 (15.3) |
Before AKI, n (%) | |
 Mechanical ventilation | 30 (41.6) |
 Surgery | 8 (11.1) |
 Aminoglycoside | 42 (58.3) |
 Indomethacin | 17 (23.6) |
 Radio-contrast | 2 (2.8) |
Vasopressor use, n (%) | 24 (33.3) |
Diuretic use, n (%) | 22 (30.6) |
Median duration of oligo-anuria among 22 patients (days) | 2 (IQR 4, range: 1–8) |
Kidney replacement therapy (peritoneal dialysis), n (%) | 7 (9.7) |